Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 31Polycystic Ovary Syndrome 9Breast Neoplasms 8Infertility 7Ovarian Hyperstimulation Syndrome 3Lymphoma 3Sarcoma, Ewing 2Sarcoma 2Prostate Adenocarcinoma 2Osteosarcoma 2Neoplasms 2Uterine Anomalies 1The Neoadjuvant Therapy 1Salpingitis 1Primary Ovarian Insufficiency 1Pregnancy, Ectopic 1Neoplasm Metastasis 1Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel 1Myofibroma 1Metabolic Syndrome 1Leiomyoma 1Infertility, Female 1Hypogonadism 1Hodgkin Disease 1Helping Behavior 1Fatty Liver 1Endometritis 1Endometriosis 1Drug-Related Side Effects and Adverse Reactions 1Castration-resistant Prostate Cancer Patients with Oligometastases 1

Interventions

testosterone undecanoate 3Testosterone 3testosterone 17 beta-cypionate 1Triptorelin Pamoate 1Testosterone Propionate 1Tamoxifen 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Practice Guidelines as Topic 1Orchiectomy 1Observation 1Methyltestosterone 1Mental Status and Dementia Tests 1Gonadotropin-Releasing Hormone 1Gels 1Drug Evaluation 1Clomiphene 1Castor Oil 1Blood Specimen Collection 1Anastrozole 1Alendronate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hypogonadism × Triptorelin Pamoate × Clear all
NCT02102646 2015-10-28

MRI Substudy; Metabolic Changes Due to Iatrogenic Hypogonadism

Herlev Hospital

Phase 4 Completed
31 enrolled
Genitourinary

Fatty Liver, Hypogonadism, Prostatic Neoplasms, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡